Sclerosis News and Research

RSS

FAU physician secures ERC Starting Grant of 1.5 million euros for cutting-edge research

Physician Dr. Andreas Ramming from Friedrich-Alexander-Universität Erlangen-Nürnberg has succeeded in securing research funding in one of the toughest European selection processes.

10 Sep 2019

FDA approves first drug to treat patients with rare lung condition

The U.S. Food and Drug Administration today approved Ofev (nintedanib) capsules to slow the rate of decline in pulmonary function in adults with interstitial lung disease associated with systemic sclerosis or scleroderma, called SSc-ILD. It is the first FDA-approved treatment for this rare lung condition.

7 Sep 2019

UA receives $37.5 million NIH grant to research potential regenerative therapy for Alzheimer's

The University of Arizona Center for Innovation in Brain Science has received a $37.5 million grant from the National Institutes of Health to research a potential regenerative therapy for Alzheimer's disease.

6 Sep 2019

Higher levels of serotonin after a seizure linked to lower incidence of breathing problems

Could a chemical produced by the brain that regulates mood, sleep and breathing also be protective in people with epilepsy? New research has found that higher levels of serotonin in the blood after a seizure are linked to a lower incidence of seizure-related breathing problems called apneas, when a person temporarily stops breathing.

5 Sep 2019

NIH trial aims to improve drug discovery for ischemic stroke

The NIH has announced it will fund a nationwide preclinical trial focusing on robust testing of new treatments for acute ischemic stroke.

4 Sep 2019

New pathological mediator of ALS found

A research collaboration based in Japan has found a new pathological mediator of amyotrophic lateral sclerosis, which could have further implications for understanding the molecular breakdown that gives rise to the neurodegenerative disease that affects nearly half a million people around the world.

3 Sep 2019

Study investigates link between social cognition and fatigue, mood in multiple sclerosis

A recent study by Kessler Foundation researchers linked the deficits in social cognition in multiple sclerosis with symptoms in other domains.

29 Aug 2019

Potential drug could revolutionize the treatment of neurological conditions

The international team of scientists from Gero Discovery LLC, the Institute of Biomedical Research of Salamanca, and Nanosyn, Inc. has found a potential drug that may prevent neuronal death through glucose metabolism modification in stressed neurons.

28 Aug 2019

AAN publishes new guideline on vaccinations for people with multiple sclerosis

Can a person with multiple sclerosis get regular vaccines? According to a new guideline, the answer is yes. The guideline, developed by the American Academy of Neurology, recommends that people with MS receive recommended vaccinations, including yearly flu shots.

28 Aug 2019

Out-of-pocket drug costs soar for Medicare patients with multiple sclerosis

Over the course of a decade, out-of-pocket costs for multiple sclerosis drugs rose more than sevenfold for Medicare Part D beneficiaries, according to a JAMA Neurology study published today by researchers at the University of Pittsburgh.

26 Aug 2019

Fasting reduces inflammation and improves chronic inflammatory diseases, study finds

Fasting regimens have gained public and scientific interest in recent years, but fasting shouldn't be dismissed as a fad. In a study published in Cell, Mount Sinai researchers found that fasting reduces inflammation and improves chronic inflammatory diseases without affecting the immune system's response to acute infections.

22 Aug 2019

New insights into protein transport could help define strategies for treating eye disease

Many forms of vision loss stem from a common source: impaired communication between the eye and the brain. And at the root of all eye-to-brain communication are the hundreds of proteins generated by the retina's nerve cells.

22 Aug 2019

Research explains why many psychiatric drugs that work in the lab don’t work in people

Current drug development for neuropsychiatric disorders is in crisis, say experts. More than 90 percent of all drugs that are developed for illnesses like schizophrenia, depression, Alzheimer’s disease (AD), or the brain tumor glioblastoma complete successful trials in mice but then come to a grinding halt in human trials, wasting billions of dollars in drug research. This is partly because of obvious behavioral differences between the two species.

22 Aug 2019

MSD collaborates with Francis Crick to find causes of motor neurone disease

Scientists at global biopharmaceutical company MSD and the Francis Crick Institute have started a unique new collaboration to understand the causes of Motor Neurone Disease and identify potential targets for future treatments, co-funded by MSD and the UK Medical Research Council.

21 Aug 2019

Cancer survivors could be at greater risk of cardiovascular diseases

Over the last few decades, medical progress has led to the survival of many more people with cancer. However, a new study published in The Lancet shows that this cohort has a higher risk of cardiovascular disease (CVD) than controls without cancer, due to a number of reasons.

21 Aug 2019

Sclerosis News and Research

FAU physician secures ERC Starting Grant of 1.5 million euros for cutting-edge research

FDA approves first drug to treat patients with rare lung condition

UA receives $37.5 million NIH grant to research potential regenerative therapy for Alzheimer's

Higher levels of serotonin after a seizure linked to lower incidence of breathing problems

NIH trial aims to improve drug discovery for ischemic stroke

New pathological mediator of ALS found

Study investigates link between social cognition and fatigue, mood in multiple sclerosis

Potential drug could revolutionize the treatment of neurological conditions

AAN publishes new guideline on vaccinations for people with multiple sclerosis

Out-of-pocket drug costs soar for Medicare patients with multiple sclerosis

Fasting reduces inflammation and improves chronic inflammatory diseases, study finds

New insights into protein transport could help define strategies for treating eye disease

Research explains why many psychiatric drugs that work in the lab don’t work in people

MSD collaborates with Francis Crick to find causes of motor neurone disease

Cancer survivors could be at greater risk of cardiovascular diseases

Researchers find possible causes for lacking of effective therapy for multiple sclerosis

Protein implicated in neuron growth and cell adhesion appears crucial for pain sensitization

Lipid signaling pathway may enhance T cell-mediated immunotherapy

Loss of cells in the brain found to be associated with stuttering

New MRI technique captures image of a brain thinking

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News